Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Cholangiocarcinoma × Photochemotherapy × Clear all

Phase

Phase 3 2 Phase 2/3 2 Phase NA 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Keratosis, Actinic 5 Squamous Cell Carcinoma of Head and Neck 4 Pancreatic Neoplasms 2 Neoplasm Metastasis 2 Liver Neoplasms 2 Colorectal Neoplasms 2 Tongue Neoplasms 1 Precancerous Conditions 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Neurofibromatosis 1 1 Neurofibroma 1 Mesothelioma, Malignant 1 Mesothelioma 1 Lymphoid Interstitial Pneumonia 1 Lung Neoplasms 1 Leukoplakia, Oral 1 Head and Neck Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Epitheliod Malignant Pleural Mesothelioma 1 Cholangiocarcinoma 1 Carcinoma, Non-Small-Cell Lung 1 Barrett Esophagus 1

Interventions

Gemcitabine 52 Cisplatin 29 Oxaliplatin 24 Fluorouracil 19 lenvatinib 18 durvalumab 18 Capecitabine 16 Leucovorin 13 pembrolizumab 9 apatinib 9 tislelizumab 7 sintilimab 6 pemigatinib 6 Radiotherapy 6 Panitumumab 6 Floxuridine 6 Albumin-Bound Paclitaxel 6 tremelimumab 5 olaparib 5 Taxes 5 Specimen Handling 5 Magnetic Resonance Spectroscopy 5 Folfox protocol 5 Drug Therapy 5 Bevacizumab 5 camrelizumab 4 Nivolumab 4 Irinotecan 4 Carboplatin 4 Biopsy 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00713687 2012-08-10

GemOx-PDT

Technical University of Munich

Phase 2 Withdrawn

Gastrointestinal

Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡